A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumorsReport as inadecuate




A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors - Download this document for free, or read online. Document in PDF available to download.

BMC Cancer

, 7:A27

First Online: 05 February 2007 Download fulltext PDF



Author: Myrna Candelaria - Dolores Gallardo-Rincón - Claudia Arce - Lucely Cetina - Jose Luis Aguilar-Ponce - Oscar Arrieta - Albe

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents